NanoString probe methodology negates the need for mRNA reverse transcription and thereby may be a more effective technique in detecting MYB–NFIB fusion in ACC patient samples, although more robust, large-scale studies are needed to confirm these preliminary results [56]. The gene discussed is NFIB; the disease is adrenal cortex carcinoma.